Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset: A Multicenter, Prospective, Randomized, Open-Label, Blinded Endpoint Trial

NCT07094763 is registered in ClinicalTrials.gov with The First Affiliated Hospital of University of Science and Technology of China as lead sponsor.

NCT NCT07094763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07094763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset: A Multicenter, Prospective, Randomized, Open-Label, Blinded Endpoint Trial
Lead sponsor
The First Affiliated Hospital of University of Science and Technology of China
Phase
Not applicable
Overall status
Recruiting
Start date
November 5, 2025
Completion date
December 30, 2027
Enrollment
406 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke